Literature DB >> 23320392

Targeting IL-1 in Sjögren's syndrome.

Akiko Yamada1, Rieko Arakaki, Yasusei Kudo, Naozumi Ishimaru.   

Abstract

INTRODUCTION: IL-1 plays key roles in the biological functions of various cells. In particular, many roles of IL-1 in the immune system have been discovered by numerous studies. This review focuses on the association of IL-1 with the pathogenesis of autoimmunity. AREAS COVERED: An overview of the biological functions of the IL-1 family and the IL-1 receptors (IL-1Rs), including the maintenance of systemic or local homeostasis, and the signaling pathway through IL-1/IL-1R in various immune systems are described. Several functions of IL-1 in the pathogenesis of Sjögren's syndrome (SS) have been demonstrated with a focus on the immune responses and target tissues in SS. In addition to the role of IL-1 in the immune responses in SS, the function of IL-1 in ocular mucosa lesions in SS has been described. Lastly, there is an overview of possible therapeutic strategies for IL-1 inhibition in SS. EXPERT OPINION: IL-1 plays critical roles in the onset and development of SS by controlling systemic or local immune responses and maintaining the survival and mucosal defense of target epithelial cells. The inhibition of the pathogenic functions of IL-1 may be beneficial for treating SS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23320392     DOI: 10.1517/14728222.2013.754427

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  10 in total

Review 1.  Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.

Authors:  Sabrina Fechtner; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

Review 2.  The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome.

Authors:  Julie Sarrand; Laurie Baglione; Dorian Parisis; Muhammad Soyfoo
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

3.  Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar Cells.

Authors:  Keiko Aota; Koichi Kani; Tomoko Yamanoi; Koh-Ichi Nakashiro; Naozumi Ishimaru; Masayuki Azuma
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 4.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 5.  Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Authors:  Giuseppe Lopalco; Luca Cantarini; Antonio Vitale; Florenzo Iannone; Maria Grazia Anelli; Laura Andreozzi; Giovanni Lapadula; Mauro Galeazzi; Donato Rigante
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

Review 6.  Role of inflammasomes in inflammatory autoimmune rheumatic diseases.

Authors:  Young-Su Yi
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

Review 7.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

8.  Decoding the Mechanism of CheReCunJin Formula in Treating Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Xiaoyu Xu; Linshuang Wang; Qian Chen; Zikang Wang; Xun Pan; Xike Peng; Miao Wang; Dongfeng Wei; Yanping Li; Bin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

Review 9.  Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms.

Authors:  Jessica E Brandt; Roberta Priori; Guido Valesini; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2015-11-03       Impact factor: 5.027

10.  Novel Immune-Related Genetic Expression for Primary Sjögren's Syndrome.

Authors:  Jiajia Cui; Hui Li; Tianling Wang; Qin Shen; Yuanhao Yang; Xiujuan Yu; Huaixia Hu
Journal:  Front Med (Lausanne)       Date:  2022-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.